The coronavirus COVID-19 is spreading to more and more countries, but until today there are no effective vaccines available on the market.
However, the search for substances that might help has been intensified over the last weeks.
The novel coronavirus COVID-19 was declared a public health emergency on January 30, 2020.
The virus has killed over 2,700 people so far and infected more than 80,000 people in approximately 38 countries. An outbreak in the U.S. becomes increasingly likely, and US health officials stated that it’s less a matter of ‘if’, but more of ‘when’.
COVID-19 already meets two out of three criterias for a pandemic: it spreads from human to human and it kills. The third criteria is spreading worldwide and it appears that COVI-19 is not far away from reaching this, too.
The novel coronavirus COVID-19 has also already reached the economy and is said to clearly have
an impact on global economic growth.
Companies like Microsoft (NYSE: MSFT) and Goldman Sachs (NYSE: GS) already downgraded their growth expectations.
The International Monetary Fund IMF also declared that the economic growth will be impacted by the COVID-19 and announced to update growth expectations soon.
Further opinions about a possible U.S. outbreak of the virus include the inevitability of an outbreak to cause a recession.
The stock market is more than concerned about the new virus. Stocks started tumbling when the coronavirus fears spread and followed European stocks on the way down.
By Wednesday morning, at only 10 am the S&P 500 was down by nearly 3% and the Dow declined by approximately 2.8%.
Even Tesla (NASDAQ: TSLA) and Apple (NASDAQ: AAPL) shares were plunging in the fear of a coronavirus pandemic.
Which stocks are worth watching during the COVID-19 crisis?
These companies currently work on ways to fight the Coronavirus:
released the first batch of mRNA-1273, the Company’s vaccine against the novel coronavirus for human use Novavax, Inc. (NASDAQ: NVAX):
assessed multiple vaccine candidates in animal models prior to identifying an optimal candidate for human testing, which is expected to begin with in spring Co-Diagnostics, Inc. (NASDAQ: CODX) :
produced a test for the coronavirus and recently received a CE Mark, tests on the efficiency with current COVID-19 are in progress Vir Biotechnology, Inc. (NASDAQ: VIR):
announced to advance and produce human monoclonal antibodies for the potential treatment of COVID-19 NanoViricides, Inc. (NYSE: NNVC):
developed nan-medicines to fight virus, such as at the swine and bird flu Inovio Pharmaceuticals, Inc. (NASDAQ: INO):
working on a vaccine to treat the MERS strain of the coronavirus